As we confirmed that IHCC organoids derived from patient #2 harbor the driver gene mutations including TP53 and IDH1, and can be stably cultured for over one year, we consider these organoids to be a cancer organoid line, although they did not form tumors on SCID mice. This evidence concerns the gene TP53 and cancer.